| Phone | 408-526-1290 |
| Employees | |
| Founded | 1989 |
GenPharm International, Inc. engages in the development and application of HuMAb-Mouse transgenic animal technology. Its technology is used in the creation of human monoclonal antibodies for therapeutic uses. The company was founded in 1989 and is based in San Jose, California. As of October 21, 1997, GenPharm International, Inc. was a subsidiary of Medarex, Inc. Later, it operates as a subsidiary of Bristol-Myers Squibb Company.
